Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bevacizumab Diminishes Inflammation in an Acute Endotoxin-Induced Uveitis Model.
Mérida S, Sancho-Tello M, Almansa I, Desco C, Peris C, Moreno ML, Villar VM, Navea A, Bosch-Morell F. Mérida S, et al. Among authors: desco c. Front Pharmacol. 2018 Jun 19;9:649. doi: 10.3389/fphar.2018.00649. eCollection 2018. Front Pharmacol. 2018. PMID: 29971005 Free PMC article.
High Myopia and the Complement System: Factor H in Myopic Maculopathy.
García-Gen E, Penadés M, Mérida S, Desco C, Araujo-Miranda R, Navea A, Bosch-Morell F. García-Gen E, et al. Among authors: desco c. J Clin Med. 2021 Jun 12;10(12):2600. doi: 10.3390/jcm10122600. J Clin Med. 2021. PMID: 34204630 Free PMC article.
The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.
Pastor-Idoate S, Rodríguez-Hernández I, Rojas J, Fernández I, García-Gutiérrez MT, Ruiz-Moreno JM, Rocha-Sousa A, Ramkissoon Y, Harsum S, MacLaren RE, Charteris D, VanMeurs JC, González-Sarmiento R, Pastor JC; Genetics on PVR Study Group. Pastor-Idoate S, et al. PLoS One. 2013 Dec 9;8(12):e82283. doi: 10.1371/journal.pone.0082283. eCollection 2013. PLoS One. 2013. PMID: 24349246 Free PMC article.
A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathy.
Rojas J, Fernandez I, Pastor JC, Maclaren RE, Ramkissoon Y, Harsum S, Charteris DG, Van Meurs JC, Amarakoon S, Ruiz-Moreno JM, Rocha-Sousa A, Brion M, Carracedo A; Genetics on PVR Study Group. Rojas J, et al. Invest Ophthalmol Vis Sci. 2013 Mar 5;54(3):1665-78. doi: 10.1167/iovs.12-10931. Invest Ophthalmol Vis Sci. 2013. PMID: 23258148
Predicting proliferative vitreoretinopathy: temporal and external validation of models based on genetic and clinical variables.
Rojas J, Fernandez I, Pastor JC, MacLaren RE, Ramkissoon Y, Harsum S, Charteris DG, Van Meurs JC, Amarakoon S, Garcia-Arumi J, Ruiz-Moreno JM, Rocha-Sousa A, Brion M, Carracedo A; Genetics on PVR Study Group (web file). Rojas J, et al. Br J Ophthalmol. 2015 Jan;99(1):41-8. doi: 10.1136/bjophthalmol-2014-305263. Epub 2014 Jul 29. Br J Ophthalmol. 2015. PMID: 25075124
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
15 results